This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


6j12

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (07:35, 1 May 2024) (edit) (undo)
 
Line 1: Line 1:
==Three-dimensional Solution NMR Structure of KYE28-PEG48 in Microgel==
==Three-dimensional Solution NMR Structure of KYE28-PEG48 in Microgel==
-
<StructureSection load='6j12' size='340' side='right' caption='[[6j12]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''>
+
<StructureSection load='6j12' size='340' side='right'caption='[[6j12]]' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[6j12]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6J12 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6J12 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[6j12]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6J12 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6J12 FirstGlance]. <br>
-
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6j12 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6j12 OCA], [http://pdbe.org/6j12 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6j12 RCSB], [http://www.ebi.ac.uk/pdbsum/6j12 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6j12 ProSAT]</span></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6j12 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6j12 OCA], [https://pdbe.org/6j12 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6j12 RCSB], [https://www.ebi.ac.uk/pdbsum/6j12 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6j12 ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
-
[[http://www.uniprot.org/uniprot/HEP2_HUMAN HEP2_HUMAN]] Defects in SERPIND1 are the cause of thrombophilia due to heparin cofactor 2 deficiency (THPH10) [MIM:[http://omim.org/entry/612356 612356]]. A hemostatic disorder characterized by a tendency to recurrent thrombosis.<ref>PMID:2647747</ref> <ref>PMID:10391209</ref> <ref>PMID:11204559</ref> <ref>PMID:15337701</ref>
+
[https://www.uniprot.org/uniprot/HEP2_HUMAN HEP2_HUMAN] Defects in SERPIND1 are the cause of thrombophilia due to heparin cofactor 2 deficiency (THPH10) [MIM:[https://omim.org/entry/612356 612356]. A hemostatic disorder characterized by a tendency to recurrent thrombosis.<ref>PMID:2647747</ref> <ref>PMID:10391209</ref> <ref>PMID:11204559</ref> <ref>PMID:15337701</ref>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/HEP2_HUMAN HEP2_HUMAN]] Thrombin inhibitor activated by the glycosaminoglycans, heparin or dermatan sulfate. In the presence of the latter, HC-II becomes the predominant thrombin inhibitor in place of antithrombin III (AT-III). Also inhibits chymotrypsin, but in a glycosaminoglycan-independent manner.<ref>PMID:1939083</ref> Peptides at the N-terminal of HC-II have chemotactic activity for both monocytes and neutrophils.<ref>PMID:1939083</ref>
+
[https://www.uniprot.org/uniprot/HEP2_HUMAN HEP2_HUMAN] Thrombin inhibitor activated by the glycosaminoglycans, heparin or dermatan sulfate. In the presence of the latter, HC-II becomes the predominant thrombin inhibitor in place of antithrombin III (AT-III). Also inhibits chymotrypsin, but in a glycosaminoglycan-independent manner.<ref>PMID:1939083</ref> Peptides at the N-terminal of HC-II have chemotactic activity for both monocytes and neutrophils.<ref>PMID:1939083</ref>
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Bhunia, A]]
+
[[Category: Homo sapiens]]
-
[[Category: Ilyas, H]]
+
[[Category: Large Structures]]
-
[[Category: Antimicrobial peptide]]
+
[[Category: Bhunia A]]
-
[[Category: Antimicrobial protein]]
+
[[Category: Ilyas H]]
-
[[Category: Drug delivery]]
+
-
[[Category: Microgel]]
+
-
[[Category: Pegylation]]
+

Current revision

Three-dimensional Solution NMR Structure of KYE28-PEG48 in Microgel

PDB ID 6j12

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools